Adult Solid Neoplasm Completed Phase 1 Trials for Nivolumab (DB09035)

IndicationStatusPhase
DBCOND0029998 (Adult Solid Neoplasm)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02775292Gene-Modified T Cells, Vaccine Therapy, and Nivolumab in Treating Patients With Stage IV or Locally Advanced Solid Tumors Expressing NY-ESO-1Treatment